• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma

tetano

Editor, Senior Moderator
PLoS One


. 2020 Sep 9;15(9):e0238089.
doi: 10.1371/journal.pone.0238089. eCollection 2020.
Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma


Lluc Farrera-Soler[SUP] 1 [/SUP], Jean-Pierre Daguer[SUP] 1 [/SUP], Sofia Barluenga[SUP] 1 [/SUP], Oscar Vadas[SUP] 2 [/SUP], Patrick Cohen[SUP] 3 [/SUP], Sabrina Pagano[SUP] 3 [/SUP], Sabine Yerly[SUP] 3 [/SUP], Laurent Kaiser[SUP] 3 4 [/SUP], Nicolas Vuilleumier[SUP] 3 [/SUP], Nicolas Winssinger[SUP] 1 [/SUP]



Affiliations

Abstract

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) is the source of a current pandemic (COVID-19) with devastating consequences in public health and economic stability. Using a peptide array to map the antibody response of plasma from healing patients (12) and heathy patients (6), we identified three immunodominant linear epitopes, two of which correspond to key proteolytic sites on the spike protein (S1/S2 and S2') known to be critical for cellular entry. We show biochemical evidence that plasma positive for the epitope adjacent to the S1/S2 cleavage site inhibits furin-mediated proteolysis of spike.
 
Back
Top Bottom